Published in J Cereb Blood Flow Metab on January 20, 2010
Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol (2012) 1.60
Upregulation of the GEF-H1 pathway after transient cerebral ischemia. Exp Neurol (2014) 1.42
Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental stroke. Exp Transl Stroke Med (2016) 1.37
Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke. Neuroscience (2012) 0.95
Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity. Cell Death Differ (2012) 0.95
Effects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests. Front Cell Neurosci (2014) 0.94
Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes. J Mol Cell Cardiol (2011) 0.93
Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions. Neurobiol Dis (2011) 0.89
Neuronal Nogo-A upregulation does not contribute to ER stress-associated apoptosis but participates in the regenerative response in the axotomized adult retina. Cell Death Differ (2011) 0.87
HMG-CoA Reductase Inhibition Promotes Neurological Recovery, Peri-Lesional Tissue Remodeling, and Contralesional Pyramidal Tract Plasticity after Focal Cerebral Ischemia. Front Cell Neurosci (2014) 0.83
Pharmacological inhibition of Rho-kinase (ROCK) signaling enhances cisplatin resistance in neuroblastoma cells. Int J Oncol (2010) 0.82
Exercise promotes axon regeneration of newborn striatonigral and corticonigral projection neurons in rats after ischemic stroke. PLoS One (2013) 0.82
A novel domain of amino-Nogo-A protects HT22 cells exposed to oxygen glucose deprivation by inhibiting NADPH oxidase activity. Cell Mol Neurobiol (2013) 0.81
Therapeutics targeting Nogo-A hold promise for stroke restoration. CNS Neurol Disord Drug Targets (2013) 0.80
Therapeutic antibodies in stroke. Transl Stroke Res (2013) 0.77
Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice. Redox Biol (2017) 0.75
Neurodegeneration and Glial Response after Acute Striatal Stroke: Histological Basis for Neuroprotective Studies. Oxid Med Cell Longev (2016) 0.75
Correlates of Post-Stroke Brain Plasticity, Relationship to Pathophysiological Settings and Implications for Human Proof-of-Concept Studies. Front Cell Neurosci (2016) 0.75
Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways. Cell Death Dis (2015) 0.75
LOTUS overexpression accelerates neuronal plasticity after focal brain ischemia in mice. PLoS One (2017) 0.75
1,026 experimental treatments in acute stroke. Ann Neurol (2006) 7.23
Glial inhibition of CNS axon regeneration. Nat Rev Neurosci (2006) 6.91
Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature (2000) 5.22
Regulation of PTEN by Rho small GTPases. Nat Cell Biol (2005) 4.51
Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature (2000) 4.30
Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med (2006) 3.23
Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature (1990) 3.22
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature (1995) 2.93
Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci (2004) 2.67
A new role for Nogo as a regulator of vascular remodeling. Nat Med (2004) 2.63
Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene (2002) 2.50
Nogo and axon regeneration. Curr Opin Neurobiol (2004) 2.48
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol (2007) 2.46
Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron (2003) 2.32
Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat Rev Neurosci (2006) 2.28
Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol (2005) 2.22
The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci (2003) 2.11
Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci (2003) 2.03
Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci (2002) 1.99
Rho kinases play an obligatory role in vertebrate embryonic organogenesis. Development (2001) 1.95
MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J (1996) 1.92
Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain (2009) 1.89
Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci (2006) 1.89
Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol (1998) 1.85
Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proc Natl Acad Sci U S A (2006) 1.76
Regulation of the PTEN phosphatase. Gene (2006) 1.69
VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain (2004) 1.67
The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J (2006) 1.64
Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Flow Metab (2005) 1.48
Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci (2001) 1.46
Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol (2002) 1.44
Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab (2003) 1.42
Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med (2005) 1.42
Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J (2005) 1.40
Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. Genes Brain Behav (2007) 1.37
Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J Neurosci (2004) 1.28
Recovery and brain reorganization after stroke in adult and aged rats. Ann Neurol (2005) 1.23
The Drosophila reticulon, Rtnl-1, has multiple differentially expressed isoforms that are associated with a sub-compartment of the endoplasmic reticulum. Cell Mol Life Sci (2006) 1.16
Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci (2006) 1.10
Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration. Curr Pharm Des (2007) 1.07
Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J Pineal Res (2008) 1.05
Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice. Neuroscience (2001) 1.02
Neurobehavioral development, adult openfield exploration and swimming navigation learning in mice with a modified beta-amyloid precursor protein gene. Behav Brain Res (1998) 1.00
Behavioral characterization of mice lacking the neurite outgrowth inhibitor Nogo-A. Genes Brain Behav (2008) 0.93
Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cells. J Pharmacol Exp Ther (2007) 0.90
Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice. Neuroscience (2009) 0.89
GTPase RhoB: an early predictor of neuronal death after transient focal ischemia in mice. Mol Cell Neurosci (2001) 0.88
Relationship of delay aversion and response inhibition to extinction learning, aggression, and sexual behaviour. Behav Brain Res (2006) 0.87
The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci (2004) 5.36
In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med (2005) 3.88
Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med (2006) 3.23
Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron (2003) 2.32
Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci (2005) 2.30
Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med (2007) 2.29
Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci (2002) 2.27
Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis (2008) 2.26
Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol (2005) 2.22
Air quality, stroke, and coronary events: results of the Heinz Nixdorf Recall Study from the Ruhr Region. Dtsch Arztebl Int (2015) 2.10
Sleep-disordered breathing and periodic limb movements in narcolepsy with cataplexy: a systematic analysis of 35 consecutive patients. Eur Neurol (2013) 2.05
Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci (2003) 2.03
Serum paraoxonase 1 activity and oxidative stress in pediatric patients with pulmonary tuberculosis. Med Princ Pract (2014) 1.99
Violence in sleep. Brain (2010) 1.92
Nogo and its paRTNers. Trends Cell Biol (2003) 1.90
Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain (2009) 1.89
Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci (2006) 1.89
Validation of the fatigue severity scale in a Swiss cohort. Sleep (2008) 1.72
Sleep-wake disturbances 3 years after traumatic brain injury. J Neurol Neurosurg Psychiatry (2010) 1.71
VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain (2004) 1.67
Constraint-induced movement therapy in the adult rat after unilateral corticospinal tract injury. J Neurosci (2008) 1.65
The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J (2006) 1.64
Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain (2007) 1.64
Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord. Eur J Neurosci (2011) 1.62
Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J Biol Chem (2005) 1.61
Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy. Brain (2013) 1.59
Reorganization of descending motor tracts in the rat spinal cord. Eur J Neurosci (2002) 1.55
Loss of hypocretin (orexin) neurons with traumatic brain injury. Ann Neurol (2009) 1.54
Deep brain stimulation of the midbrain locomotor region improves paretic hindlimb function after spinal cord injury in rats. Sci Transl Med (2013) 1.53
TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiol Dis (2008) 1.52
Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci (2003) 1.52
Sleep homeostasis in the rat is preserved during chronic sleep restriction. Proc Natl Acad Sci U S A (2010) 1.49
Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity. Philos Trans R Soc Lond B Biol Sci (2006) 1.48
Effects of sleep fragmentation on the arousability to resistive loading in NREM and REM sleep in normal men. Sleep (2006) 1.48
Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Flow Metab (2005) 1.48
Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1. Neurobiol Dis (2005) 1.45
Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol (2002) 1.44
Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med (2005) 1.42
Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab (2003) 1.42
A reticular rhapsody: phylogenic evolution and nomenclature of the RTN/Nogo gene family. FASEB J (2003) 1.42
Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J (2005) 1.40
Sleep-related breathing and sleep-wake disturbances in ischemic stroke. Neurology (2009) 1.39
Characterization of epidermal neural crest stem cell (EPI-NCSC) grafts in the lesioned spinal cord. Mol Cell Neurosci (2006) 1.38
Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord. J Neurosci (2002) 1.31
Neural stem/precursor cells for the treatment of ischemic stroke. J Neurol Sci (2007) 1.31
Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol (2004) 1.31
Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci (2006) 1.31
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. J Neurochem (2007) 1.30
Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity. Brain (2011) 1.29
Functional and anatomical reorganization of the sensory-motor cortex after incomplete spinal cord injury in adult rats. J Neurosci (2009) 1.28
Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury. Brain (2009) 1.25
Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J (2004) 1.25
Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med (2004) 1.25
Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. Brain (2007) 1.24
The clinical spectrum of narcolepsy with cataplexy: a reappraisal. J Sleep Res (2004) 1.24
Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol (2003) 1.23
Recovery and brain reorganization after stroke in adult and aged rats. Ann Neurol (2005) 1.23
Nogo-A stabilizes the architecture of hippocampal neurons. J Neurosci (2010) 1.22
The role of Nogo-A in axonal plasticity, regrowth and repair. Cell Tissue Res (2012) 1.22
Dendritic plasticity in the adult rat following middle cerebral artery occlusion and Nogo-a neutralization. Cereb Cortex (2005) 1.22
Rewiring of hindlimb corticospinal neurons after spinal cord injury. Nat Neurosci (2009) 1.20
Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci (2008) 1.18
NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc Natl Acad Sci U S A (2011) 1.18
Animal models of ischemic stroke. Part two: modeling cerebral ischemia. Open Neurol J (2010) 1.18
Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motoneurons. Exp Neurol (2009) 1.18
Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J Comp Neurol (2007) 1.17
Anti-Nogo on the go: from animal models to a clinical trial. Ann N Y Acad Sci (2010) 1.17
Synaptic destabilization by neuronal Nogo-A. Brain Cell Biol (2007) 1.17
Red nucleus projections to distinct motor neuron pools in the rat spinal cord. J Comp Neurol (2002) 1.16
Dissociation of periodic leg movements from arousals in restless legs syndrome. Ann Neurol (2012) 1.14
Neuronal Nogo-A regulates neurite fasciculation, branching and extension in the developing nervous system. Development (2010) 1.13
MicroRNA-124 protects against focal cerebral ischemia via mechanisms involving Usp14-dependent REST degradation. Acta Neuropathol (2013) 1.13
Combination treatment with anti-Nogo-A and chondroitinase ABC is more effective than single treatments at enhancing functional recovery after spinal cord injury. Eur J Neurosci (2013) 1.12
Morphological differences in Parkinson's disease with and without rest tremor. J Neurol (2009) 1.12
Long-distance axonal regeneration induced by CNTF gene transfer is impaired by axonal misguidance in the injured adult optic nerve. Neurobiol Dis (2012) 1.10
Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci (2006) 1.10
Pincher-generated Nogo-A endosomes mediate growth cone collapse and retrograde signaling. J Cell Biol (2010) 1.09
The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep (2006) 1.09
Endothelial dysfunction and arterial stiffness in ischemic stroke: the role of sleep-disordered breathing. Stroke (2013) 1.08
c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress. Circulation (2008) 1.08
Defeating inhibition of regeneration by scar and myelin components. Handb Clin Neurol (2012) 1.07